Tone mix
Week by week 52 weeks
Share of BioMarin Pharmaceuticals Inc's 148 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 24, 2026 · tone -99Weekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks-141
- Week of Sep 29, 2025 · tone +100Growth and Pipeline Keep BioMarin Pharmaceutical Inc. (BMRN) Attractive for Investors+114
- Week of May 25, 2026 · tone -100Canaccord Genuity Group Lowers BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $111.00-110
- Week of Sep 8, 2025 · tone -99Why BioMarin Pharmaceutical (BMRN) Stock Is Down Today-108
- Week of Oct 6, 2025 · tone +100BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: A 71.68% Potential Upside With Robust Revenue Growth+100
- Week of Oct 12, 2026 · tone +100BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Expected to Rise, Barclays Analyst Says+91
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about BioMarin Pharmaceuticals Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | -50 |
| Last 30 sessions | 10 | +19 |
| Last 90 sessions | 34 | +29 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletAnalyzing BeyondSpring (NASDAQ:BYSI) and BioMarin Pharmaceutical (NASDAQ:BMRN)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Analyzing BeyondSpring (NASDAQ:BYSI) and BioMarin Pharmaceutical (NASDAQ:BMRN) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletMorgan Stanley Issues Pessimistic Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock PriceNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Morgan Stanley Issues Pessimistic Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price | www.themarketsdaily.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletBioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by UBS GroupPositive
- www.tickerreport.com · 1 outletCritical Survey: XTL Biopharmaceuticals (NASDAQ:XTLB) & BioMarin Pharmaceutical (NASDAQ:BMRN)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by UBS Group | www.tickerreport.com | 1 | Positive |
| Critical Survey: XTL Biopharmaceuticals (NASDAQ:XTLB) & BioMarin Pharmaceutical (NASDAQ:BMRN) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletBioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Expected to Rise, Barclays Analyst SaysPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Expected to Rise, Barclays Analyst Says | www.themarketsdaily.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 8, 2026
1 headline, average tone +95: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Has Average Price Target of $89.17 According to BrokeragesPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Has Average Price Target of $89.17 According to Brokerages | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about BioMarin Pharmaceuticals Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.